The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India
- PMID: 14523288
- DOI: 10.1097/00002030-200310170-00019
The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India
Abstract
We investigated the safety, tolerability and effectiveness of locally produced generic highly active antiretroviral therapy (HAART) regimens with a chart review conducted at YRG CARE, a tertiary HIV referral centre in India. A total of 333 patients had been on Indian-manufactured generic HAART for at least 3 months. In this cohort, generic HAART was safe, well tolerated and effective at increasing CD4 T-lymphocyte counts in patients with advanced HIV, comparable to the experience with proprietary HAART.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials